Ursprung des Netzwerks ersten Grades von Kai Lähdesmäki
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kai Lähdesmäki
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMMUNICON CORP. | Medical Specialties | Director/Board Member | |
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
| BEIERSDORF | Household/Personal Care | Corporate Officer/Principal | |
| MEDIGENE AG | Biotechnology | Chief Executive Officer | |
| CONNECT GROUP NV | Electronic Production Equipment | Director/Board Member | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
| Technical University of Berlin | College/University | Doctorate Degree | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member | |
| EPIGENOMICS AG | Medical Specialties | Chief Executive Officer | |
Sanofi-Aventis Deutschland GmbH
 Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| Tampere University of Technology | College/University | Graduate Degree | |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Chairman | |
| Faron Ventures Oy | Director/Board Member | ||
Inveni Capital Oy
 Inveni Capital Oy Investment ManagersFinance Inveni Capital Oy is a venture capital investment firm with offices in Helsinki and Munich. The Finnish-German firm was founded in 2007. Their investors include the Finnish Industry Investment Ltd. as largest single investor, along with other private investors and funds as well as the University of Helsinki. | Investment Managers | Private Equity Investor | |
| University of Kuopio | College/University | Graduate Degree | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Founder | |
Sitra Management Oy
 Sitra Management Oy Investment ManagersFinance Sitra Management Oy (Sitra) is a venture capital subsidiary of the Government of Finland founded in 1967. The firm is headquartered in Helsinki, Finland. | Investment Managers | Director/Board Member | |
| Scibase AB | Director/Board Member | ||
| Belgian Venturing Association ASBL | President | ||
| ATON | Pharmaceuticals: Major | Director/Board Member | |
| European Private Equity & Venture Capital Association | Director/Board Member | ||
Becap BV
 Becap BV Investment ManagersFinance Becap BVBA is an independent private equity investment firm founded in 2006 by Piet Serrure. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
| University of Antwerp | College/University | Graduate Degree | |
Visys NV
 Visys NV Industrial MachineryProducer Manufacturing Visys NV provides digital automated sorting solutions to the global food and non-food processing industry. It offers optical sorting systems and machinery, and digital laser sorters, non-food products by detecting and removing foreign bodies. The company was founded by Frank L. A. Zwerts and Bert Peelaers in 2004 and is headquartered in Hasselt, Belgium. | Industrial Machinery | Director/Board Member | |
| University of Turku | College/University | Doctorate Degree | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree |
Statistik
International
| Deutschland | 13 |
| Finnland | 11 |
| Belgien | 9 |
| Vereinigte Staaten | 6 |
| Schweden | 3 |
Sektoral
| Health Technology | 19 |
| Finance | 7 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 43 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 14 |
| President | 11 |
| Chairman | 9 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kai Lähdesmäki
- Unternehmensverbindungen
